Celldex Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND CLDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

22,237

Value ($000)

604

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	604	0.0%	22,237	12/31/2025
2025 Q3	11/3/2025	575	0.0%	22,237	9/30/2025
2025 Q2	10/8/2025	453	0.0%	22,237	6/30/2025
2025 Q1	10/8/2025	404	0.0%	22,237	3/31/2025
2024 Q4	10/8/2025	562	0.0%	22,237	12/31/2024
2024 Q3	10/8/2025	756	0.0%	22,237	9/30/2024
2024 Q2	10/8/2025	1,101	0.0%	29,737	6/30/2024
2024 Q1	10/8/2025	1,124	0.0%	26,790	3/31/2024
2023 Q4	10/8/2025	877	0.0%	22,116	12/31/2023
2023 Q3	10/8/2025	654	0.0%	23,780	9/30/2023
2023 Q2	10/8/2025	779	0.0%	22,959	6/30/2023
2023 Q1	10/8/2025	991	0.0%	27,545	3/31/2023
2022 Q4	10/8/2025	1,457	0.0%	32,679	12/31/2022
2022 Q3	11/8/2022	920	0.0%	32,719	9/30/2022
2022 Q2	8/4/2022	879	0.0%	32,622	6/30/2022
2022 Q1	7/1/2022	1,114	0.0%	32,705	3/31/2022
2021 Q4	2/2/2022	1,263	0.0%	32,681	12/31/2021
2021 Q3	11/2/2021	1,648	0.0%	30,516	9/30/2021
2021 Q2	8/2/2021	1,124	0.0%	33,600	6/30/2021